Globus Medical, Inc. GMED
Set alert
79.82 USD +0.36 +0.46%
As of Nov 3, 10:45 AM ET
78.61 Day range 79.89
60.26 52-week range 101.40
- YTD
- -8.58%
- 1 year
- +30.43%
- Open
- 78.64
- Prev close
- 79.46
- Mkt cap
- 10.72B
- Vol
- 208.16K
- Avg vol
- 1.42M
- EPS
- 3.90
- P/E
- 20.48
- Div yield
- 0.00%
More statistics
- Low
- 78.61
- High
- 79.89
- Forward P/E
- 14.74
- Beta
- 0.95
- Short ratio
- 5.17
- Inst. own
- 94.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 77.62
- 200-d avg
- 83.50
- 1y target
- 100.92
5D chart
Signals (91)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 3:50 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 3:35 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 3:35 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:20 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 1:25 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:10 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:45 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 12:45 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 12:35 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 11:55 AM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 11:50 AM | 22 hours ago |
Newest 20 of 91.
Analyst view
Consensus: buy
Buy
Price target (mean) 100.92 +26.4% upside
Now 79.82
- Target (low)
- 84.00
- Target (mean)
- 100.92
- Target (high)
- 125.00
Ratings (0m) 14 10 buy · 4 hold · 0 sell
- Strong buy3
- Buy7
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.20 | 1.13 – 1.26 | 1.18 | +1.4% | 792.46M | +3.0% | 13 |
| Next quarter | 1.34 | 1.31 – 1.39 | 1.28 | +4.6% | 857.71M | +3.8% | 13 |
| Current year | 5.00 | 4.97 – 5.05 | 3.98 | +25.6% | 3.20B | +8.9% | 14 |
| Next year | 5.39 | 5.10 – 5.62 | 5.00 | +7.8% | 3.39B | +6.0% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 28, 2026 | UBS | Initiated | — | Neutral |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | Initiated | — | Outperform |
| Jul 8, 2026 | Stifel | Maintained | Hold | Hold |
| Jun 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 8, 2026 | Needham | Maintained | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Jan 30, 2026 | Needham | Upgrade | Hold | Buy |
| Jan 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 8, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 17, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 17, 2025 | Freedom Capital Markets | Initiated | — | Hold |
| Dec 2, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 10, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 7, 2025 | B of A Securities | Upgrade | Neutral | Buy |
| Nov 7, 2025 | Truist Securities | Upgrade | Hold | Buy |
| Oct 10, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |